间质细胞
浆液性液体
癌症研究
卵巢癌
恶性转化
BRCA突变
间充质干细胞
生物
基质
细胞
癌症
干细胞
癌细胞
医学
病理
免疫学
细胞生物学
遗传学
免疫组织化学
作者
Geyon L. Garcia,Taylor Orellana,Grace Kelly Rodrigues,Leonard Frisbie,Roja Baruwal,Sindhuja Suresh,Ester Goldfeld,Ian Beddows,Ian P. MacFawn,Ananya K. Britt,Macy M. Hale,Amal Elhaw,Brian Isett,Nadine Hempel,Riyue Bao,Hui Shen,Ronald J. Buckanovich,Toren Finkel,Ronny Drapkin,T. Rinda Soong
标识
DOI:10.1158/2159-8290.cd-24-0805
摘要
Abstract The fundamental steps in high-grade serous ovarian cancer (HGSOC) initiation are unclear presenting critical barriers in prevention and early detection of this deadly disease. Current models propose that fallopian tube epithelial (FTE) cells transform into serous tubal intraepithelial carcinoma (STIC) precursor lesions and subsequently HGSOC. Here we report that an epigenetically altered mesenchymal stem cell niche, termed high risk MSC (hrMSC), exists prior to STIC lesion formation. hrMSCs are enriched in STIC stroma and contribute to a stromal ‘field effect’ extending beyond the borders of STIC lesion. hrMSCs promote DNA damage in FTE cells while also fostering FTE cell survival. hrMSCs induce malignant transformation of FTE resulting in metastatic cancer in vivo, indicating hrMSCs promote cancer initiation. hrMSCs are significantly enriched in BRCA1/2 mutation carriers and increase with age. Combined, these findings indicate that hrMSCs can incite ovarian cancer initiation and have important implications for ovarian cancer detection and prevention.
科研通智能强力驱动
Strongly Powered by AbleSci AI